Clinical
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program
3
Top Infectious Disease News Stories Week of October 11-October 17
4
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Postantibiotic Era
5
